ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 134 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2019. The put-call ratio across all filers is 3.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $275,000 | – | 9,196 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TIGER MANAGEMENT L.L.C. | 1,115,411 | $45,576,000 | 7.97% |
Rappaport Reiches Capital Management, LLC | 133,330 | $5,447,864 | 5.73% |
Matrix Capital Management Company, LP | 11,800,090 | $482,152,000 | 5.27% |
Asymmetry Capital Management, L.P. | 168,172 | $6,872,000 | 4.72% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $1,225,543,000 | 3.72% |
Eagle Health Investments LP | 257,827 | $10,535,000 | 3.61% |
BERYLSON CAPITAL PARTNERS, LLC | 246,200 | $10,060,000 | 2.23% |
Aristotle Atlantic Partners, LLC | 717,650 | $29,323,000 | 1.93% |
DDD Partners, LLC | 250,382 | $10,231,000 | 1.55% |
Casdin Capital, LLC | 1,440,000 | $58,838,000 | 1.49% |